no more compounded tirzepatide Ivím Health Compounded Tirzepatide for Weight Loss

The lower dose means less medication per vial, which translates to lower cost

These include the SURPASS trials , which focus on people with type 2 diabetes, and the SURMOUNT trials , which focus on people with obesity or overweight who do not have diabetes

compiled from community dosing logs and reconstitution guides documentation of what sources describe, not a recommendation): Self-reported starting doses begin around 125 mcg weekly for 2-4 weeks to assess tolerance, before increasing to 250 mcg

As with many new medications, its essential to monitor any side effects closely and report them to a healthcare provider

The 3-month commitment was my biggest hesitation